Director, Neurofibromatosis Research Initiative
Division of Genetics and Genomics, Boston Children’s Hospital
Boston, Massachusetts, United States
Dr. Miller is an Associate Professor of Pediatrics at Harvard Medical School and Director of the Multidisciplinary Neurofibromatosis (NF) Clinic and the Neurofibromatosis Research Initiative (NFRI) at Boston Children’s Hospital. Through the NFRI, he created the international Genomics of MPNST (GeM) Consortium, an effort to characterize the genomic architecture of this rare NF1-related tumor to facilitate more effective clinical management.
He has led or served on several national committees and advisory boards focused on best practices for clinical genetics and genetic testing, including: Chair of ACMG’s Professional Practice and Guidelines Committee (where he led the 2019 update of “Health Supervision for Children with Neurofibromatosis Type 1,” a joint guideline of the AAP and ACMG); Co-Chair of ACMG’s Secondary Findings Maintenance Working Group; Member of ACMG’s Evidence-Based Medicine Working Group; and Deputy Editor of ACMG’s journal, Genetics in Medicine.
He received his M.D. and Ph.D. from Washington University School of Medicine in St. Louis, completed a residency in Pediatrics at Yale-New Haven Hospital, and residency/fellowship in Clinical Genetics and Clinical Molecular Genetics at Harvard Medical School. He is board-certified in Clinical Genetics and Clinical Molecular Genetics.
Thursday, November 17, 2022
10:15 AM – 10:25 AM